AAAAAA
Results: 76-100/640
Authors:
CHAUVAUD D
Citation: D. Chauvaud, HUMAN OCULAR MICROANGIOPATHY, Therapie, 52(5), 1997, pp. 453-456
Authors:
STRIKER LJ
Citation: Lj. Striker, RENAL MICROANGIOPATHY IN DIABETES, Therapie, 52(5), 1997, pp. 457-458
Authors:
MOULIN B
Citation: B. Moulin, PREVENTING THE PROGRESSION OF DIABETIC NE PHROPATHY USING ANTIHYPERTENSIVE THERAPY, Therapie, 52(5), 1997, pp. 459-460
Authors:
FONTAINE P
Citation: P. Fontaine, MANAGEMENT OF DIABETIC VASCULOPATHY, Therapie, 52(5), 1997, pp. 461-471
Authors:
GIULIANO F
Citation: F. Giuliano, SEXUAL IMPOTENCE AND DIABETES-MELLITUS, Therapie, 52(5), 1997, pp. 473-473
Authors:
MAHIEUX F
LACOMBLEZ L
Citation: F. Mahieux et L. Lacomblez, MEETING OF THE MEMORY CONSULTING UNITS - 1ST FEBRUARY 1997 PARIS, Therapie, 52(5), 1997, pp. 475-475
Authors:
DEROUESNE C
Citation: C. Derouesne, WHICH MEMORY CLINICS AND FOR WHOM, Therapie, 52(5), 1997, pp. 477-480
Authors:
MICHEL BF
PASQUIER F
MAHIEUX F
Citation: Bf. Michel et al., MEMORY CONSULTING UNITS - LONG-TERM FOLLO W-UP, Therapie, 52(5), 1997, pp. 481-482
Authors:
OUSSET PJ
RIGAUD AS
METAIS P
Citation: Pj. Ousset et al., MEMORY CONSULTING UNITS - EXTENT OF DAY H OSPITAL, Therapie, 52(5), 1997, pp. 483-485
Authors:
ALLAIN H
BAUDOIN V
DUBOIS B
FORETTE F
Citation: H. Allain et al., THE PLACE OF CLINICAL-TRIALS IN MEMORY CL INICS, Therapie, 52(5), 1997, pp. 487-489
Authors:
PAZART L
DUPUY M
DUROCHER A
Citation: L. Pazart et al., HOW TO ASSESS CLINICAL HEALTH-CARE, Therapie, 52(5), 1997, pp. 491-494
Authors:
DEMONET JF
GELYNARGEOT MC
BAKCHINE S
Citation: Jf. Demonet et al., METHODOLOGICAL ASPECTS OF COGNITIVE ASSES SMENTS, Therapie, 52(5), 1997, pp. 495-498
Authors:
GUEGUEN B
TOUCHON J
CAMPION D
Citation: B. Gueguen et al., MNESIC COMPLAINTS AND EARLY DEMENTIA - WH ICH INVESTIGATIONS AND FOR WHOM, Therapie, 52(5), 1997, pp. 499-502
Authors:
DARTIGUES JF
FABRIGOULE C
LETENNEUR L
AMIEVA H
THIESSARD F
ORGOGOZO JM
Citation: Jf. Dartigues et al., EPIDEMIOLOGY OF MEMORY DISORDERS, Therapie, 52(5), 1997, pp. 503-506
Authors:
LEBERT F
THOMASANTERION C
LETORTU O
Citation: F. Lebert et al., AFFECTIVE SYMPTOMS - INFLUENCE ON MEMORY DEFICITS, Therapie, 52(5), 1997, pp. 507-508
Authors:
LAURENT B
VANDERLINDEN M
CHERIF AA
HIBERT O
TRUCHE A
Citation: B. Laurent et al., MEMORY REHABILITATION - STRATEGIES, LIMIT S AND INDICATIONS, Therapie, 52(5), 1997, pp. 509-513
Authors:
CORVAISIER S
BLEYZAC N
CONFESSON MA
BUREAU C
MAIRE P
Citation: S. Corvaisier et al., A POPULATION-MODEL FOR AMIKACIN IN NON-IN SULIN-DEPENDENT DIABETIC-PATIENTS USING THE NON PARAMETRIC SOFTWARE NPEM2 (VOL 52, PG 219, 1997), Therapie, 52(5), 1997, pp. 515-515
Authors:
SASSARD P
LIBERSA C
Citation: P. Sassard et C. Libersa, ANNUAL-MEETINGS OF THE FRENCH-SOCIETY-OF- PHARMACOLOGY (MARSEILLES 1997 NANCY 1998), Therapie, 52(4), 1997, pp. 249-249
Authors:
SAHNOUN Z
JAMOUSSI K
ZEGHAL KM
Citation: Z. Sahnoun et al., FREE-RADICALS - FUNDAMENTAL NOTIONS AND M ETHODS OF EXPLORATION, Therapie, 52(4), 1997, pp. 251-270
Authors:
JAILLON P
DUPUIS B
DAHAN R
BOTTINEAU G
CARON J
CAZOR JL
CHAUVENET M
CLEMENT JP
ESCANDE D
FAISANDIER Y
FUNCKBRENTANO C
KOLSKY H
KOEN R
LACROIX D
LEENHARDT A
LEHNER JP
PROST JF
SWYNGHEDAUW B
VASSORT G
WEISSENBURGER J
WOHLHUTER C
Citation: P. Jaillon et al., DRUG-INDUCED TORSADE-DE-POINTES - PRECLIN ICAL AND CLINICAL-STUDIES FOR THE PREDICTION OF A POTENTIAL PROARRHYTHMIC ADVERSE DRUG REACTION, Therapie, 52(4), 1997, pp. 271-280
Authors:
BOISSEL JP
PERRET L
BOUVENOT G
CASTAIGNE A
GERARDCOUE MJ
MAILLERE P
MISMETTI P
VRAY M
AVOUAC B
BEGAUD B
CAULIN C
CHARPAK Y
CHAUMETRIFFAUD P
COSTAGLIOLA D
DEGOS F
DESTORS JM
DOYON F
FAGNANI F
GIRI I
GIRRE JP
GOEHRS JM
KHER A
MOCCATTI D
MUNOZ A
DECURZON AP
PLETAN Y
ROY P
VASMANT D
WAJMAN A
Citation: Jp. Boissel et al., INTERMEDIATE AND SURROGATE OUTCOMES IN CL INICAL-EVALUATION OF DRUGS, Therapie, 52(4), 1997, pp. 281-285
Authors:
MARTY M
BIZARRI JP",MIGNOT,LOKIEC,ARMAND,LECHEVALIER,GUILLOUZO,CROISY,ROUGIER,GOUYETTE,HILL,MAHJOUBI,CLERGEOT,HURTELOUP,TRUTMAT,BAYSSAS,TANAHFISCH,TRUNET,AZAB,ABADIE,SALORD,MATHIEUBONE,CAULIN
Citation: M. Marty et Bizarri Jp",mignot,lokiec,armand,lechevalier,guillouzo,croisy,rougier,gouyette,hill,mahjoubi,clergeot,hurteloup,trutmat,bayssas,tanahfisch,trunet,azab,abadie,salord,mathieubone,caulin, NOTE FOR GUIDANCE ON THE EVALUATION OF AN TICANCER AGENTS IN MAN, Therapie, 52(4), 1997, pp. 287-290
Authors:
LECHAT P
CANET E
BELLISSANT E
BILLAUD E
BROUARD R
BRUGUEROLLE B
BRUNO R
CUDENNEC C
DEGOS L
DIQUET B
DUBRUC C
GARAFFO R
HUMBERT H
JOCHENSEN R
LAURENT S
LAURIN S
LAVEILLE C
MENTRE F
PAINTAUD G
ROSENZWEIG P
SIMON P
THIBAULT N
THUILLEZ C
WAROT D
Citation: P. Lechat et al., DETERMINATION OF TIME-DEPENDENT EFFECT PR OFILE OF DRUGS, Therapie, 52(4), 1997, pp. 291-298
Authors:
HERVE P
LEPECQ JB
Citation: P. Herve et Jb. Lepecq, CELL THERAPY, A NEW MEDICAL-PRACTICE, Therapie, 52(4), 1997, pp. 299-305
Authors:
ELEFANT E
SAINTECROIX A
Citation: E. Elefant et A. Saintecroix, EVALUATION OF DRUG RISK DURING PREGNANCY - METHODOLOGY AND RISK MANAGEMENT, Therapie, 52(4), 1997, pp. 307-312